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SNORING IS A SIGN OF INCREASED UPPER AIRWAY 
RESISTANCE, AND OBSTRUCTIVE SLEEP APNEA IS 
CHARACTERIZED BY RECURRENT EPISODES OF UP-
PER airway obstruction during sleep. Excessive daytime 
sleepiness is common among heavy snorers and among patients 
with obstructive sleep apnea syndrome.1-3 A number of recent 
prospective studies report than patients with obstructive sleep 
apnea run an increased risk of stroke and early death.4-8
Surgical treatment for snoring and obstructive sleep apnea 
aims to increase the upper airway cross-sectional area, remove 
obstructive tissues, such as enlarged tonsils, or bypass the upper 
airway. Uvulopalatopharyngoplasty became popular shortly after 
its introduction in 1981.9 The uvula, the distal part of the soft 
palate and the tonsils are removed, with the aim of enlarging the 
oropharyngeal airspace and thereby reducing sleep apneas, snor-
ing, and daytime sleepiness. Laser-assisted uvulopalatoplasty and 
temperature-controlled radiofrequency tissue ablation were sub-
sequently introduced, and these surgical modalities could be per-
formed under local anesthesia. Other surgical modalities include 
tracheostomy, inferior sagittal mandibular osteotomy and genio-
glossus advancement with hyoid myotomy and suspension, laser 
midline glossectomy and lingual plasty, maxillo-mandibular os-
teotomy and advancement, expansion sphincter pharyngoplasty, 
palatal implants, nasal surgery, epiglottoplasty for selected cases 
of laryngomalacia, and so on. The efficacy of surgical modalities 
has, however, been questioned in systematic reports, and laser-
assisted uvulopalatopharyngoplasty is not recommended for the 
treatment of sleep disordered breathing.10-14 There is a lack of sys-
tematic reviews of adverse effects, as many subjects still undergo 
surgery because of snoring and sleep apnea.
The present aim was systematically to review studies of the 
efficacy and adverse effects of surgery for snoring and obstruc-
tive sleep apnea in adults.
methods
search strategy
PubMed and the Cochrane Controlled Trials Register were 
searched on 1 September 2007; (“Sleep apnea syndromes” 
surgery for snoring and osa
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study objectives: Many patients undergo surgery for snoring and 
sleep apnea, although the efficacy and safety of such procedures have 
not been clearly established. Our aim was systematically to review 
studies of the efficacy and adverse effects of surgery for snoring and 
obstructive sleep apnea.
design: Systematic review.
measurements: PubMed and Cochrane databases were searched 
in September 2007. Randomized controlled trials of surgery vs. sham 
surgery or conservative treatment in adults, with daytime sleepiness, 
quality of life, apnea-hypopnea index, and snoring as outcomes were 
included. Observational studies were also reviewed to assess adverse 
effects. Evidence of effect required at least two studies of medium and 
high quality reporting the same result.
results: Four studies of benefits and 45 studies of adverse effects were 
included. There was no significant effect on daytime sleepiness and qual-
ity of life after laser-assisted uvulopalatoplasty and radiofrequency abla-
tion. The apnea-hypopnea index and snoring was reduced in one trial 
after laser-assisted uvulopalatoplasty but not in another trial. Subjective 
snoring was reduced in one trial after radiofrequency ablation. No trial 
investigating the effect of any other surgical modality met the inclusion 
criteria. Persistent side-effects occurred after uvulopalatopharyngoplasty 
and uvulopalatoplasty in about half the patients and difficulty in swallow-
ing, globus sensation and voice changes were especially common.
Conclusions: Only a small number of randomized controlled trials with 
a limited number of patients assessing some surgical modalities for 
snoring or sleep apnea are available. These studies do not provide 
any evidence of effect from laser-assisted uvulopalatoplasty or radiof-
requency ablation on daytime sleepiness, apnea reduction, quality of 
life or snoring. We call for research of randomized, controlled trials of 
surgery other than uvulopalatopharyngoplasty and uvulopalatoplasty, 
as they are related to a high risk of long-term side-effects, especially 
difficulty swallowing.
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[Mesh] OR “Snoring” [Mesh]) AND (“Surgery” [Mesh] OR 
“Surgery” [Subheading] or Radiofrequency) Limits: English, 
Randomized Controlled Trial, Meta-Analysis.
PubMed was searched on 1 September 2007 for side-effects; 
sleep apnea syndromes/surgery [Mesh] OR snoring/surgery 
[Mesh] AND (adverse effects [Mesh Subheading] OR compli-
cations [Mesh subheading] OR complication [Text Word] OR 
complications [Text Word]) NOT (comment [Publication Type] 
OR editorial [Publication Type] OR news [Publication Type]) 
Limits: English.
Reference lists of all the identified articles were searched for 
additional studies.
inclusion Criteria for the selection of articles and study end 
Points
Two reviewers independently screened abstracts according to 
inclusion criteria. For all possibly relevant articles, full reports 
were requested. Randomized, controlled studies of medium 
and high quality comparing surgery for snoring or obstructive 
sleep apnea with sham operations or conservative treatment 
were included. The primary outcomes were daytime sleepiness 
measured using the Epworth Sleepiness Scale, Multiple sleep 
latency test or Maintenance of wakefulness test and Quality of 
life. Secondary outcomes were the apnea-hypopnea index and 
severity of snoring.
The review of adverse effects included randomized, con-
trolled studies and observational studies of medium and high 
quality reporting complications and side-effects of surgery other 
than post-operative pain. All studies reporting life-threatening 
side effects and deaths in relation to surgery were included.
Quality assessment and evidence grading
A modified JADAD ranking scale from 0-5 was used to assess 
the quality of randomized, controlled trials.13,15 We used questions 
on single blinding instead of double blinding, with the following 
questions: Was the trial described as randomized? Was the allo-
cation concealed? Were patients blinded to treatment alternative? 
Were investigators blinded to treatment alternative? Was there 
a description of withdrawals? A score of 0-2 was rated as poor 
quality, 3 as medium quality, and 4-5 as high quality.
The following scores were used for observational studies re-
porting side-effects. High quality required a prospective study; 
before and after data for adverse effects; defined groups of pa-
tients and a detailed description of methods and adverse effects; 
loss to follow-up of less than 30%. Medium quality required a 
prospective design or consecutive patients; a summary descrip-
tion of patients and methods; a detailed description of adverse 
effects; loss to follow-up of less than 30%.
Strong evidence required at least two studies of high quality 
reporting the same result. Moderate evidence required at least 
one study of high quality and two of medium quality, while lim-
ited evidence required at least two studies of medium quality.
data abstraction
The data were independently abstracted by two reviewers and 
the authors were contacted in the event of questions. The number 
of participants, baseline characteristics, type of surgery, time of 
follow-up, design, benefits and adverse effects were extracted.
statistical analysis
Means and 95% confidence interval (CI) for change in active 
treated patients compared with control patients was calculated 
from mean of change (after - before) and standard deviation 
of change (SD). Differences of mean change between active 
treatment and control treatment were presented with 95% con-
fidence interval (95% CI). A significant effect was regarded 
when 0 was not included in the confidence interval. For meta-
analysis, we used Cochrane Review Manager software (ver-
sion 5.0; Cochrane Library Software, Oxford, England). Means 
and SD for change in outcome was entered in the analysis. The 
weighted mean difference was used for comparisons of change 
in difference between active treatment and control. A P-value of 
< 0.05 was considered significant. Weighted means for adverse 
effects were calculated as = Σ ni/n * pi. Where ni = number of 
treated patients, n = sum of all treated patients and pi = propor-
tion of patients with an adverse effect.
results
efficacy
There were 64 hits in the search, and 15 potentially relevant 
articles were read. Five randomized controlled trials compar-
ing surgery with sham surgery or conservative treatment were 
identified (Figure 1). One trial comparing uvulopalatopharyn-
goplasty and conservative treatment was excluded from further 
analysis due to low quality and a modified JADAD score of 2.16 
Four parallel, randomized, controlled trials of high quality met 
the inclusion criteria, 2 studies investigated the effect of laser-
assisted uvulopalatoplasty and 2 the effect of radiofrequency 
ablation (Table 1).17-20
A summary of the effects on outcome for the difference in 
change is presented in Table 2. These studies show no sig-
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Figure 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 Potentially relevant 
RCTs identified  
4 RCTs included in 
the meta-analysis 
1 RCT withdrawn 
because of low quality 
5 Potentially 
appropriate RCTs to 
be included in meta-
analysis   
10 RCTs excluded as 
they did not fulfil 
inclusion criteria 
15 RCT retrieved for 
more detailed analysis  
49 Excluded by the 
abstract evaluation 
45 Studies included in 
the analysis on 
adverse effects  
34 Studies excluded 
from analysis because 
of low quality 
79 Potentially 
appropriate studies to 
be included in analysis 
23 Studies excluded 
because they did not 
address adverse effects 
102 Studies retrieved 
for more detailed 
analysis  
530 Studies excluded 
by abstract evaluation 
632 Potentially 
relevant studies on 
adverse effects 
Figure 1—Flowchart of the process of study selection.
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Table 1—Description of Included Studies of Medium and High Quality
Source Location Study
design
Sample size* Operation Outcomes Quality
Ferguson et al., 200317 Canada RCT, parallel 46 (45) LAUP ESS, AHI, SAQLI, 
Snoring, Side-
effects
High
Woodson et al., 200318 USA RCT, parallel 60 (52) TCRAFTA ESS, AHI, SF36, 
FOSQ, Side-effects
High
Larossa et al., 200419 Spain RCT, parallel 28 (25) LAUP ESS, AHI, 
SF36, Snoring, 
Complications
High
Stuck et al., 200520 Germany RCT, parallel 26 (23) TCRAFTA ESS, Snoring, Side- 
effects
High
Studies of adverse effects 
Esclamado et al., 198923 USA Consecutive patients 132 UPPP Perioperative 
complications
Medium
Harmon et al., 198924 USA Consecutive patients 132 UPPP Peri- and 
postoperative 
complications
Medium
Walker et al., 199625 USA Consecutive patients 275 LAUP Postoperative 
complications
Medium
Riley et al., 199726 USA Prospective 182 (182) Different 
operations
Postoperative 
complications
Medium
Mickelson et al., 199827 USA Consecutive patients 347 UPPP Postoperative 
complications
Medium
Terris et al., 199828 USA Consecutive patients 109 (109) UPPP Peri- and 
postoperative 
complications
Medium
Hultcrantz et al., 199929 Sweden Consecutive patients 55 UPP Long-term side-
effects
Medium
Levring-Jäghagen et al., 
199930
Sweden Consecutive patients 76 (68) UPP Persistent dysphagia Medium
Powell et al., 199931 USA Prospective 20 (18) TCRAFTA
tongue
Postoperative 
complications, 
swallowing function
Medium
Remacle et al., 199932 Belgium Prospective 89 LAUP
UPPP
Complications Medium
Boudewyns et al., 200033 Belgium Prospective 103 (44) TCRAFTA
soft palate
Postoperative 
complications
Medium
Coleman et al., 200034 USA Prospective 12 TCRAFTA soft 
palate
Postoperative 
complications
Medium
Grontved et al., 200035 Denmark Consecutive patients 69 UPPP Complications Medium
Hagert et al., 200036 Sweden Consecutive patients 457 (415) UPPP
LAUP
Long-term side-
effects
Medium
Hukins et al., 200037 Australia Prospective 20 TCRAFTA soft 
palate
Postoperative 
complications
Medium
Li et al., 200038 USA Prospective 22 TCRAFTA
soft palate
Long term side-
effects
Medium
Osman et al., 200039 UK Prospective 47 (47) UPPP
LAUP
Postoperative 
complications
Medium
Bäck et al.. 200140 Finland Prospective 21 (16) TCRAFTA
soft palate
Postoperative 
complications
Medium
(continued on following page)
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laser-assisted uvulopalatoplasty
Ferguson et al. randomized 46 snoring patients with an 
apnea-hypopnea index of between 10 and 27 to laser-assisted 
uvulopalatoplasty or no treatment and followed them for 7 
months.17 There was no significant between-group difference in 
the Epworth Sleepiness Scale or the Calgary Sleep Apnea Qual-
ity of Life Index. The mean apnea-hypopnea index was reduced 
from 19 to 15 in the actively treated patients and increased from 
16 to 23 in non-treated patients, P = 0.04 for the between-group 
difference in change. Snoring intensity estimated by a bedroom 
nificant effect on daytime sleepiness measured with the Ep-
worth sleepiness scale after laser-assisted uvulopalatoplasty 
and temperature-controlled, radiofrequency tissue ablation 
(Figure 2). The apnea-hypopnea index and snoring was re-
duced in one trial after laser-assisted uvulopalatoplasty17 but 
not in another trial.19 Subjective snoring was reduced, but not 
the apnea-hypopnea index in one trial after radiofrequency 
ablation.18 There was no effect on quality of life in any trial. 
No trial investigating the effect of any other surgical modality 
met the inclusion criteria.
Table 1—Description of Included Studies of Medium and High Quality (continued from previous page)
Source Location Study
design
Sample size* Operation Outcomes Quality
Brown et al., 200141 Canada Prospective 12 TCRAFTA soft 
palate
Postoperative 
complications
Medium
Pazos et al., 200142 USA Consecutive patients 30 (30) TCRAFTA soft 
palate, tongue
Postoperative 
complications
Medium
Sher et al., 200143 USA Prospective 112 (105) TCRAFTA
soft palate
Postoperative 
complications
Medium
Terris et al., 200145 USA Prospective 23 TCRAFTA soft 
palate
Postoperative 
complications
Medium
Woodson et al., 200146 USA Prospective 73 (69) TCRAFTA tongue Postoperative 
complications
Medium
Haraldsson et al., 200247 Sweden Prospective 16 TCRAFTA
soft palate
Speech evaluation Medium
Lysdahl et al., 200248 Sweden Consecutive patients 150 (121) UPPP
LAUP
Long-term side-
effects
Medium
Stuck et al., 200244 Germany Prospective 20 (18) TCRAFTA soft 
palate, tongue
Postoperative 
complications
Medium
Berger et al., 200349 Israel Prospective 49 UPPP
LAUP
Early and long-term 
side-effects
Medium
Rombaux et al., 200350 Belgium Prospective 49 UPPP
LAUP
TCRAFTA soft 
palate
Postoperative 
complications
Medium
Said et al., 200351 USA Consecutive patients 50 (39) TCRAFTA soft 
palate
Postoperative 
complications
Medium
Jäghagen et al., 200422 Sweden Prospective 46 (42) UPPP
UPP
Swallowing 
function
High
Kezirian et al., 200421 USA Prospective 3130 UPPP Postoperative 
serious side-effects
High
Kim et al., 200552 South Korea Consecutive patients 90 UPPP Postoperative 
complications
Medium
Li et al.,54 China Consecutive patients 108 UPPP Taste disturbances Medium
Pavelec et al., 200653 Czech 
Republic
Prospective 63 LAUP Postoperative 
complications
Medium
Abbreviations: RCT, randomized, controlled trial; ESS, Epworth sleepiness scale; SF36 Short Form 36; AHI, Apnea-hypopnea index; FOSQ, 
functional outcome of sleep questionnaire; SAQLI, Calgary Sleep Apnea Quality of Life Index; LAUP, laser-assisted uvulopalatoplasty; UPP, 
uvulopalatopharyngoplasty; UPPP, uvulopalatopharyngoplasty; TCRAFTA, temperature-controlled radiofrequency tissue ablation. *Num-
bers in parentheses denote the number of patients analyzed after withdrawals.
Surgery for Snoring and Sleep Apnea—Franklin et al
SLEEP, Vol. 32, No. 1, 2009 31
lation, compared with sham surgery, improved Functional Out-
comes of Sleep Questionnaire with a mean of 0.9 (95% CI -0.1, 
1.9) P = 0.04 and reduced the apnea index with a mean of –4.8 
(–9.3, 0.4) P = 0.02. These P-values were, however, significant 
only in one sided t-test but not in 2-sided nonparametric test, 
and 0 was included in confidence interval (Table 2). They found 
no significant difference in change for the Epworth Sleepiness 
Scale, Short-Form 36 Physical component summary, Short-
Form 36 Mental component summary or the apnea-hypopnea 
index.
Stuck et al. randomized 26 non-sleepy snorers with an ap-
nea-hypopnea index < 15, a body-mass index < 35 kg/m2 and 
a mean Epworth sleepiness scale of 8.2 (1.4) to temperature-
controlled radiofrequency ablation or sham surgery.20 There 
was no between-group difference in change in the Epworth 
Sleepiness Scale. The authors report that snoring estimated 
by a bedroom partner on a VAS scale from 0-10 was reduced 
by surgery compared with sham surgery from a mean of 8.1 
to 5.2 and by sham surgery from 8.4 to 8.0, P = 0.045 for the 
difference in change.
partner on a VAS scale from 0-10 was reduced by surgery from 
a mean of 9.2 to 4.8 and by no treatment from 8.9 to 8.5, P 
< 0.0001 for the between-group difference in change. Snoring 
frequency was reduced from a mean of 9.4 to 5.5 in surgically 
treated patients and from 8.8 to 8.5 in non-treated patients, P < 
0.005.
Larossa et al. randomized 28 snoring patients with an ap-
nea-hypopnea index < 30 to laser-assisted uvulopalatoplasty or 
sham surgery and followed them for 3 months.19 They found no 
significant difference in change in any of the outcomes, i.e. the 
Epworth Sleepiness Scale, Short-Form 36 Physical component 
summary, Short-Form 36 Mental component summary, Sub-
jective snoring intensity, Snoring index or Decibels of snoring 
(Table 2).
temperature-Controlled radiofrequency tissue ablation
Woodson et al. performed the largest study and randomized 
60 patients with daytime sleepiness, an apnea-hypopnea index 
of 5 to 40 and a body-mass index < 35 kg/m2 to radiofrequency 
ablation or sham surgery.18 They report that radiofrequency ab-
Figure 2—Effect of surgery on daytime sleepiness using the Epworth sleepiness scale.
Table 2—Effects of Surgery Compared to Placebo or No Treatment
 LAUP LAUP TCRAFTA TCRAFTA
 Ferguson et al., 200317 Larossa et al., 200419 Woodson et al., 200318 Stuck et al., 200520
ESS -2.2 (-15, 9.3) -0.4 (-13, 12) -1.2 (-3.1, 0.8) -0.6 (-1.2, 2.3)
FOSQ   -0.9 (-0.1, 1.9) 
SAQLI 0.2 (-0.6, 1.0)   
SF-36 Physical  1.4 (-38, 41) -1.0 (-5.1, 3.1) 
SF-36 Mental  -2 (-49, 45) 2.5 (-1.4, 6.4) 
AHI -10.5, P = 0.04 7 (-76, 90) -2.7 (-9.9, 4.5) 
Snoring intensity -4.0 (-5.5, -2.5)* -1.1 (-12, 10)  
Snoring frequency -3.6 (-1.3, -5.9)* -106 (-8753, 8541)  
Snoring subjective  -0.5 (-3.8, 2.8)  -2.5 (-4.6, -0.4)*
*Significant as 0 was not included in the confidence interval.
Abbreviations: LAUP, laser-assisted uvulopalatoplasty; TCRAFTA, temperature-controlled radiofrequency tissue ablation; ESS, Epworth 
sleepiness scale; NS, No significant change. SF36 Short Form 36; FOSQ, functional outcome of sleep questionnaire; SAQLI, Calgary Sleep 
Apnea Quality of Life Index; AHI, Apnea-hypopnea index
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uvulopalatoplasty
Uvulopalatoplasty performed with a scalpel or laser was fol-
lowed by peri- and post-operative complications in up to 5%, 
including post-operative bleedings and infections, with one re-
port of death from septicemia (Tables 3).17,19,25,39,50,58 Persistent 
side-effects were reported in a mean (range) of 59% (48% to 
62%) (limited evidence; Table 5).29,36,49 Difficulty swallowing 
including nasal regurgitation was reported in 27% (19% to 31%) 
(strong evidence) and globus sensation in 27% (16% to 36%) 
(limited evidence).17,22,29,30,32,36,48,53 Other reported side-effects 
included voice changes, smell disturbances, taste disturbances, 
and single cases of velopharyngeal stenosis.36,49
temperature-Controlled radiofrequency tissue ablation
There were no reported changes in speech or swallowing 
one to two months after surgery.18,20,38,47 Side-effects of tem-
perature-controlled, radiofrequency tissue ablation of the soft 
palate included hemorrhage, infections and velopharyngeal 
fistula in single cases.33,50 Radiofrequency ablation of the base 
of the tongue was followed by severe infections or tongue ab-
scesses in 0% to 8% of patients (moderate evidence).18,31,42,44,46 
Single cases of mouth floor edema, severe tongue swell-
ing, and a case of pseudo-aneurysm of the lingual artery 
and heavy bleeding 14 days after surgery have also been 
reported.42,44,46,92
other surgical modalities
No studies of any other surgical modality meeting the inclu-
sion criteria for adverse effects were found.
adverse effects
There were 632 hits in the search and 102 potentially relevant 
articles were read. Seventy-nine trials met the inclusion criteria. 
Five of the included studies were of high quality,17,18,20-22 and 33 
were of medium quality (Table 1).19,23-54. Forty-one studies were 
of low quality and they were excluded from further analysis, 
except for 7 studies reporting life-threatening side-effects and 
deaths55-95 (Figure 1).
uvulopalatopharyngoplasty
Uvulopalatopharyngoplasty was followed by severe compli-
cations in the peri- and post-operative period, including death, 
bleedings and respiratory compromise, in 0% to 16% of pa-
tients, with higher frequencies in studies published during the 
1980s and lower complication frequencies in studies in recent 
years.21,23,24,26-28,39,50,52,58,60,77,94
A total of 30 cases of death were reported from six studies 
published between 1989 and 2004 (Table 3). One high-quality 
study comprising 3,130 operations reported peri- and post-op-
erative death in 0.2% (95% CI 0.1 to 0.4) and serious complica-
tions other than death in 1.5% (95% CI 1.1 to1.9).21 Respiratory 
compromise, bleedings, intubation difficulties, infections, and 
cardiac arrest were the main causes of death. Persistent side-
effects occurred in a mean (range) of 58% (42%–62%) (limited 
evidence; Table 4).35,36 Difficulty swallowing, including nasal 
regurgitation, occurred in 31% (13% to 36%) of operated pa-
tients (moderate evidence), voice changes in 13% (7% to 14%) 
(limited evidence), and taste disturbances in 5% (1% to 7%) 
(limited evidence).22,35,36,48,54 Other reported side-effects were 
globus sensation, smell disturbances, and single cases of ve-
lopharyngeal insufficiency.36,55
Table 3—Deaths in the Peri- and Postoperative Period
Author Operation Death case Source population Reasons Quality
  numbers numbers for death 
Esclamado 198923 UPPP 1 135 Intubation problems Medium
USA     
Harmon 198924 UPPP 2 132 Bleeding (n = 1) Medium
USA    Pulmonary embolism (n = 1) 
Fairbanks 199057 UPPP 16  Bleeding (n = 1) Low
USA    Loss of airway (n = 12) 
    Unknown (n = 3) 
Carenfelt 199358 UPPP 3 9000 Cardiac arrest (n = 2) Low
Sweden LAUP 1 2900 Bleeding (n = 1) 
    Infection (n = 1) 
Haavisto 199460 UPPP 1 101 Breathing difficulties Low
Finland    and asystole (n = 1) 
Lee 199762 UPPP or 6  Respiratory arrest (n = 1) Low
UK LAUP   Cardiac arrest (n = 1) 
    Unknown (n = 4) 
Kezirian 200421 UPPP 7 3130 Unknown (n = 4) High
USA    Respiratory problems (n = 2) 
    Cardiac arrest (n = 1) 
Abbreviations: UPPP, uvulopalatopharyngoplasty; LAUP, laser-assisted uvulopalatoplasty.
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more invasive surgery, is the problem of performing placebo or 
sham surgery in the control group. Instead of placebo, we suggest 
that control patients should be randomized to delayed surgery. In 
subsequent systematic reviews we suggest that other quality crite-
ria than pure JADAD should be used in quality assessments. We 
used a modified JADAD focusing on the quality of single blind-
ing instead of double blinding. If patients and surgeons cannot be 
blinded, one can always try to blind the assessors.
To date, the best study of peri- and post-operative mortal-
ity was published by Kezirian et al. in 2004. They reported a 
mortality of 0.2% among all Veterans Affairs inpatient uvulo-
palatopharyngoplasty surgery from 1991 to 2001 and serious 
peri- and post-operative complications in 1.5% of patients.21 
However, without evidence of effects of the surgical procedures, 
it is difficult to accept mortality related to surgery. Two cohort 
studies followed long-term mortality after uvulopalatophar-
yngoplasty and they report low mortality in the long term for 
these patients compared with untreated patients and patients on 
CPAP.97,98 These studies were, however, not randomized con-
trolled trials, and surgically treated patients were younger and 
had less comorbidity than those treated with CPAP.
This systematic review included only randomized, controlled 
trials of medium and high quality regarding the efficacy of sur-
gery. The lack of evidence of benefits of surgery is in agreement 
with a Cochrane review11 and recent reviews by Elshaug et 
al.12,14 Only a few randomized controlled trials were, however, 
available, even though surgery for obstructive sleep apnea was 
introduced more than 25 years ago. To evaluate adverse effects, 
we included observational studies of medium and high qual-
disCussion
Randomized, controlled trials do not support any benefit 
from surgery in the form of laser-assisted uvulopalatoplasty and 
temperature-controlled radiofrequency tissue ablation when it 
comes to daytime sleepiness or quality of life. Studies do not 
provide any evidence of effect on apnea-hypopnea index or 
snoring as there is a need of at least two trials reporting ef-
fect for evidence grading. One study reported a reduction in the 
apnea-hypopnea index and snoring after laser-assisted uvulo-
palatoplasty, while no such effects were found in another trial. 
A single study reported a reduction in snoring after radiofre-
quency tissue ablation. No evidence of effect was established 
for any other surgical modality, as no randomized, controlled 
trial meeting the inclusion criteria was found for any other sur-
gical modality. Persistent side-effects were reported in a major-
ity of the patients undergoing uvulopalatopharyngoplasty and 
uvulopalatoplasty, especially in the form of difficulty swallow-
ing, globus sensation in the throat, and voice changes.
Only four controlled trials randomizing a total of 141 patients 
to either laser-assisted uvulopalatopharyngoplasty and sham/no 
treatment, or temperature-controlled radiofrequency tissue abla-
tion and sham surgery met the present inclusion criteria. From this 
small sample of trials, it is not possible to exclude any effect of 
surgery. However, the many reports of swallowing difficulties af-
ter uvulopalatopharyngoplasty and uvulopalatoplasty suggest that 
other surgical modalities than these two should be further tested. 
Tonsillectomy is one suggested modality as large tonsils are asso-
ciated with sleep apnea.96 One disadvantage of surgery, especially 
Table 4—Side-Effects After Uvulopalatopharyngoplasty
 Author Frequency Weighted mean Evidence grade
Persistent side-effects Hagert 200036 62% 58% Limited
 Grontved 200035 42%  
Difficulty swallowing Hagert 200036 35% 31% Moderate
 Grontved 200035 13%  
 Lysdahl 200248 36%  
 Jäghagen 200422 29%  
Voice changes Hagert 200036 14% 13% Limited
 Grontved 200035 7%  
Taste disturbances Hagert 200036 7% 5% Limited
 Li 200654 1%
Table 5—Side-Effects After Uvulopalatoplasty
 Author Frequency Weighted mean Evidence grade
Persistent side-effects Hultcranz 199929 56% 59% Limited
 Hagert 200036 62%  
 Berger 200349 48%  
Difficulty swallowing Levring-Jäghagen 199930 20% 27% Strong
 Hultcranz 199929 19%  
 Hagert 200036 31%  
 Lysdahl 200248 27%  
 Ferguson 200317 19%  
 Jäghagen 200422 29%  
Globus sensation in throat Hultcranz 199929 19% 27% Limited
 Hagert 200036 36%  
 Pavelec 200653 16%  
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